These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17510970)

  • 1. Differential prognostic impact of comorbidity in head and neck cancer.
    Alho OP; Hannula K; Luokkala A; Teppo H; Koivunen P; Kantola S
    Head Neck; 2007 Oct; 29(10):913-8. PubMed ID: 17510970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
    Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
    Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
    Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
    J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Washington University Head and Neck Comorbidity Index in a cohort of older patients.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):603-7. PubMed ID: 18559726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.
    Datema FR; Ferrier MB; van der Schroeff MP; Baatenburg de Jong RJ
    Head Neck; 2010 Jun; 32(6):728-36. PubMed ID: 19827120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of comorbidity in salivary gland carcinoma.
    Terhaard CH; van der Schroeff MP; van Schie K; Eerenstein SE; Lubsen H; Kaanders JH; Smeele LE; Burlage FR; van Den Ende PL; Baatenburg de Jong RJ
    Cancer; 2008 Oct; 113(7):1572-9. PubMed ID: 18704992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
    Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
    Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck.
    Barra S; Barzan L; Maione A; Cadelano A; Pin M; Franceschi S; Comoretto R
    Laryngoscope; 1994 Jan; 104(1 Pt 1):95-8. PubMed ID: 8295465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
    Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
    J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of comorbidity and age on survival with laryngeal cancer.
    Sabin SL; Rosenfeld RM; Sundaram K; Har-el G; Lucente FE
    Ear Nose Throat J; 1999 Aug; 78(8):578, 581-4. PubMed ID: 10485151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
    Golger A; Young DS; Ghazarian D; Neligan PC
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age as a prognostic factor for complications of major head and neck surgery.
    Boruk M; Chernobilsky B; Rosenfeld RM; Har-El G
    Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):605-9. PubMed ID: 16027283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative importance of diagnostic delays in different head and neck cancers.
    Teppo H; Alho OP
    Clin Otolaryngol; 2008 Aug; 33(4):325-30. PubMed ID: 18983341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
    Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
    Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic relevance of age and comorbidity in patients with resected gastric cancer].
    Bollschweiler E; Breckheimer S; Mönig SP; Hölscher AH
    Zentralbl Chir; 2009 Feb; 134(1):71-6. PubMed ID: 19242886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
    J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.